40405108,40394512,40378056,40267824,40209444,40209441,40199195,39641624,40388682,40402951,40392873[uid] - Search Results

Year	Number of Results
2024	1
2025	11

1

Identifying the germline variation spectrum and predisposition genes in Chinese ovarian cancer using whole exome sequencing.

Guan X, Liao S, Zhang F, Zhu Q, Qiu H, Qin L, Zhang X. Guan X, et al. BMC Cancer. 2025 May 22;25(1):924. doi: 10.1186/s12885-025-14302-w. BMC Cancer. 2025. PMID: 40405108 Free PMC article.

2

A CT-based radiomics model for predicting progression-free survival in patients with epithelial ovarian cancer.

Leng Y, Zhou J, Liu W, Luo F, Peng F, Gong L. Leng Y, et al. BMC Cancer. 2025 May 20;25(1):899. doi: 10.1186/s12885-025-14265-y. BMC Cancer. 2025. PMID: 40394512 Free PMC article.

3

Unravelling the tumor microenvironment and PD-L1 expression across tissue type in high-grade serous ovarian cancer in the NeoPembrOV/GINECO phase II randomized trial.

Collet L, Ardin M, Venet D, Berthet J, Ghamry-Barrin S, Treilleux I, Noel JC, Leheurteur M, Meunier J, Bengrine Lefevre L, Martinez M, Priou F, Selle F, Just PA, Bataillon G, Rothé F, Sotiriou C, Caux C, Dubois B, Ray-Coquard I, Le Saux O. Collet L, et al. Clin Cancer Res. 2025 May 16. doi: 10.1158/1078-0432.CCR-24-2712. Online ahead of print. Clin Cancer Res. 2025. PMID: 40378056

4

External validation of the IOTA two-step strategy in the preoperative characterization of ovarian masses.

Einig S, Puls T, Reina H, Schoetzau A, Montavon C, Butenschön A, Heinzelmann-Schwarz V, Manegold-Brauer G. Einig S, et al. Eur J Obstet Gynecol Reprod Biol. 2025 Jun;310:113981. doi: 10.1016/j.ejogrb.2025.113981. Epub 2025 Apr 17. Eur J Obstet Gynecol Reprod Biol. 2025. PMID: 40267824 Free article.

5

Hysterectomy or not for borderline ovarian tumor in menopause?

Raimondo D, Raffone A, Maletta M, Restaino S, Arcieri M, Driul L, Travaglino A, Perrone AM, Fagotti A, Mascilini F, Malzoni M, Falcone F, Bogani G, Ferla S, Landoni F, Berretta R, Ceccaroni M, Cicogna S, Pantano F, Trojano G, Sami K, Chiara C, Chiantera V, Alboni C, Solima E, Scarfone G, Martinello R, Manna P, Pecorino B, Vastarella MG, Calandra D, Paccapelo A, Lenzi J, Cobellis L, Scambia G, Vizzielli G, Seracchioli R. Raimondo D, et al. Gynecol Oncol. 2025 May;196:152-159. doi: 10.1016/j.ygyno.2025.03.052. Epub 2025 Apr 9. Gynecol Oncol. 2025. PMID: 40209444

6

Genetic predictors of unexpected recurrence in low-risk endometrial cancer: A comprehensive genomic analysis reveals FGFR2 as a risk factor and a rare fatal POLE-mutated recurrence.

Mettälä T, Joutsiniemi T, Huvila J, Hietanen S. Mettälä T, et al. Gynecol Oncol. 2025 May;196:129-136. doi: 10.1016/j.ygyno.2025.03.038. Epub 2025 Apr 9. Gynecol Oncol. 2025. PMID: 40209441 Free article.

7

ECPPF stratification identifies occult high-risk subgroups in stage I, grade 1 or 2, ≤50 % invasive endometrial cancer: Candidates for adjuvant therapy.

Gonzalez-Bosquet J, Shahi M, Yadav S, Kanwar N, Alvand S, Sosa C, Dowdy SC, Halling KC, Weroha SJ, Bakkum-Gamez JN, Podratz KC. Gonzalez-Bosquet J, et al. Gynecol Oncol. 2025 May;196:113-120. doi: 10.1016/j.ygyno.2025.03.030. Epub 2025 Apr 7. Gynecol Oncol. 2025. PMID: 40199195

8

Unusual synchronous and metachronous association of hematologic neoplasms with gynecologic neoplasms: A case series and literature review.

Ozcivit Erkan IB, Kuru O, Turker Saricoban C, Wardak M, Hamzaoglu Canbolat K, Eskazan AE. Ozcivit Erkan IB, et al. Int J Gynaecol Obstet. 2025 Jun;169(3):1025-1036. doi: 10.1002/ijgo.16075. Epub 2024 Dec 6. Int J Gynaecol Obstet. 2025. PMID: 39641624

9

Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer.

Shah M, Chen TY, Ison G, Fiero MH, Zhang H, Gao X, Neilson M, Goldberg KB, Nair A, Ricks TK, Pierce WF, Gormley N, Theoret MR, Tang S, Pazdur R, Kluetz PG, Amiri-Kordestani L. Shah M, et al. J Clin Oncol. 2025 Jul;43(19):2218-2227. doi: 10.1200/JCO-24-02834. Epub 2025 May 19. J Clin Oncol. 2025. PMID: 40388682 Review.

10

Epigenetic assessments of alcohol consumption predict mortality in smokers at risk for lung cancer in the prostate, lung, colorectal and ovarian cancer screening trial.

Philibert R, Beach SRH, Mills JA, Dawes K, Hoffman RM, Sieren JC, Froehlich EM, deBlois KM, Long JD. Philibert R, et al. PLoS One. 2025 May 22;20(5):e0322783. doi: 10.1371/journal.pone.0322783. eCollection 2025. PLoS One. 2025. PMID: 40402951 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year